Author:
Zhang Mingxia,Wu Jiannan,Mao Kai,Deng Heran,Yang Yaping,Zhou Enxiang,Liu Jieqiong
Funder
National Natural Science Foundation of China
Key Laboratory of Malignant Tumor Molecular Mechanism and Translational Medicine of Guangzhou Bureau of Science and Information Technology
Key Laboratory of Malignant Tumor Gene Regulation and Target Therapy of Guangdong Higher Education Institutes
Reference22 articles.
1. Triple-negative breast cancer;Foulkes;N. Engl. J. Med.,2010
2. Triple-negative breast cancer: clinicopathological characteristics and relationship with basal-like breast cancer;Thike;Mod. Pathol.,2010
3. Triple-negative breast cancer: therapeutic options;Cleator;Lancet Oncol.,2007
4. Descriptive analysis of estrogen receptor (ER)-negative, progesterone receptor (PR)-negative, and HER2-negative invasive breast cancer, the so-called triple-negative phenotype: a population-based study from the California cancer registry;Bauer;Cancer-Am Cancer Soc.,2007
5. Race and triple negative threats to breast cancer survival: a population-based study in Atlanta;Lund;Ga. Breast Cancer Res. Treat.,2009